- Home
- GRX vs ELTX Comparison
GRX vs ELTX Comparison
Compare GRX & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRX
- ELTX
- Stock Information
- Founded
- GRX 2007
- ELTX 2011
- Country
- GRX United States
- ELTX United States
- Employees
- GRX N/A
- ELTX N/A
- Industry
- GRX Finance/Investors Services
- ELTX Biotechnology: Pharmaceutical Preparations
- Sector
- GRX Finance
- ELTX Health Care
- Exchange
- GRX Nasdaq
- ELTX Nasdaq
- Market Cap
- GRX 142.7M
- ELTX 158.5M
- IPO Year
- GRX N/A
- ELTX N/A
- Fundamental
- Price
- GRX $9.32
- ELTX $8.95
- Analyst Decision
- GRX
- ELTX Strong Buy
- Analyst Count
- GRX 0
- ELTX 1
- Target Price
- GRX N/A
- ELTX $13.00
- AVG Volume (30 Days)
- GRX 39.7K
- ELTX 97.5K
- Earning Date
- GRX 01-01-0001
- ELTX 11-07-2025
- Dividend Yield
- GRX 5.98%
- ELTX N/A
- EPS Growth
- GRX N/A
- ELTX N/A
- EPS
- GRX 0.26
- ELTX N/A
- Revenue
- GRX N/A
- ELTX N/A
- Revenue This Year
- GRX N/A
- ELTX N/A
- Revenue Next Year
- GRX N/A
- ELTX N/A
- P/E Ratio
- GRX $38.50
- ELTX N/A
- Revenue Growth
- GRX N/A
- ELTX N/A
- 52 Week Low
- GRX $7.73
- ELTX $4.60
- 52 Week High
- GRX $10.40
- ELTX $12.62
- Technical
- Relative Strength Index (RSI)
- GRX 55.32
- ELTX 31.60
- Support Level
- GRX $9.08
- ELTX $9.03
- Resistance Level
- GRX $9.32
- ELTX $9.55
- Average True Range (ATR)
- GRX 0.09
- ELTX 0.43
- MACD
- GRX -0.00
- ELTX -0.04
- Stochastic Oscillator
- GRX 85.19
- ELTX 1.60
About GRX The Gabelli Healthcare & Wellness Trust of Beneficial Interest
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.